These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 11119565

  • 21. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G, Titus RG, Cerottini JC, Marchal G, Louis JA.
    J Immunol; 1986 Feb 15; 136(4):1467-71. PubMed ID: 2418115
    [Abstract] [Full Text] [Related]

  • 22. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S, Debrabant A, Afrin F, Caler E, Mendez S, Tabbara KS, Belkaid Y, Sacks DL.
    Infect Immun; 2005 Oct 15; 73(10):6620-8. PubMed ID: 16177338
    [Abstract] [Full Text] [Related]

  • 23. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
    Daneshvar H, Coombs GH, Hagan P, Phillips RS.
    J Infect Dis; 2003 May 15; 187(10):1662-8. PubMed ID: 12721947
    [Abstract] [Full Text] [Related]

  • 24. Control of Leishmania major by a monoclonal alpha beta T cell repertoire.
    Reiner SL, Fowell DJ, Moskowitz NH, Swier K, Brown DR, Brown CR, Turck CW, Scott PA, Killeen N, Locksley RM.
    J Immunol; 1998 Jan 15; 160(2):884-9. PubMed ID: 9551925
    [Abstract] [Full Text] [Related]

  • 25. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM, Coffman RL.
    J Immunol; 1993 Jun 15; 150(12):5476-83. PubMed ID: 8515072
    [Abstract] [Full Text] [Related]

  • 26. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease.
    Hoerauf A, Solbach W, Röllinghoff M, Gessner A.
    Int Immunol; 1995 Nov 15; 7(11):1879-84. PubMed ID: 8580086
    [Abstract] [Full Text] [Related]

  • 27. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 15; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

  • 28. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites.
    Wolfram M, Ilg T, Mottram JC, Overath P.
    Eur J Immunol; 1995 Apr 15; 25(4):1094-100. PubMed ID: 7737279
    [Abstract] [Full Text] [Related]

  • 29. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP, MacDonald HR, Louis JA.
    J Immunol; 1993 Jan 15; 150(2):550-5. PubMed ID: 8419488
    [Abstract] [Full Text] [Related]

  • 30. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major.
    Brown JA, Greenwald RJ, Scott S, Schweitzer AN, Satoskar AR, Chung C, Schopf LR, van der Woude D, Sypek JP, Sharpe AH.
    Eur J Immunol; 2002 Jun 15; 32(6):1764-72. PubMed ID: 12115660
    [Abstract] [Full Text] [Related]

  • 31. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
    Gamboa-León MR, Aranda-González I, Mut-Martín M, García-Miss MR, Dumonteil E.
    Scand J Immunol; 2007 Nov 15; 66(5):508-14. PubMed ID: 17953527
    [Abstract] [Full Text] [Related]

  • 32. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 33. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
    Daneshvar H, Hagan P, Phillips RS.
    Parasite Immunol; 2003 Jul 15; 25(11-12):589-96. PubMed ID: 15053780
    [Abstract] [Full Text] [Related]

  • 34. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 35. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.
    Barral-Netto M, de Freitas LA, Andrade ZA.
    Am J Pathol; 1987 May 28; 127(2):271-8. PubMed ID: 3495185
    [Abstract] [Full Text] [Related]

  • 36. Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major.
    Cillari E, Dieli M, Lo Campo P, Sireci G, Caffarelli A, Maltese E, Millott S, Milano S, Liew FY.
    Immunology; 1991 Sep 28; 74(1):25-30. PubMed ID: 1718853
    [Abstract] [Full Text] [Related]

  • 37. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, Gollob KJ.
    Infect Immun; 2001 May 28; 69(5):3232-9. PubMed ID: 11292745
    [Abstract] [Full Text] [Related]

  • 38. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 28; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 39. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R, Oghumu S, Dong R, Peterson A, Sharpe AH, Satoskar AR.
    Exp Parasitol; 2015 Jan 28; 148():49-55. PubMed ID: 25447125
    [Abstract] [Full Text] [Related]

  • 40. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK, Titus RG.
    Am J Trop Med Hyg; 2007 Mar 28; 76(3):579-84. PubMed ID: 17360887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.